METHODS OF MODIFYING TRANSCRIPTIONAL REGULATORY NETWORKS IN STEM CELLS

Patent №

US 9,732,128

Granted

2017-08-15

Filed 2011

Owner

BIOTIME, INC.

+1 more

Lab

AI components

1

hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

13279123

The vast differentiation potential of human embryonic and induced pluripotent stem cells, including their potential to cascade through all of the somatic cell lineages and to display the complete transcriptional regulatory network of human biology, has generated interest in deriving scalable, purified, and identified cell types and methods of discovering the precise structure of the human regulatory network. However, the innate capacity of pluripotent cells to display all these lineages is not necessarily reflected during their culture in vitro. The clonal isolation and propagation of progenitors greatly facilitates the generation of highly purified and identified formulations for research and therapeutic purposes. Nevertheless, other cell types have yet to be isolated and propagated from normal cells and methods of isolating said novel cell types as well as methods for introducing perturbations into the transcriptional regulatory network in order to construct a computer model of the entire human transcriptional regulatory network would greatly benefit basic research as well as manufacturing technology for cell-based therapies.

AI hardwareC07K 14/4702C12N 5/0696C12N 2501/602C12N 2501/603

AI classification

AI hardware0.96
Natural language0.01
Vision0.00
Evolutionary computation0.00
Planning0.00
Speech0.00
Machine learning0.00
Knowledge representation0.00

Ownership

BIOTIME, INC.

assignment · 277780195

LINEAGE CELL THERAPEUTICS, INC.

namechg · 531970627

Assignors

WEST, MICHAEL D., CHAPMAN, KAREN B.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC